Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity Targeting Chimeras) therapeutics, today ...

He stressed the importance of early detection through Prostate-Specific Antigen (PSA) blood tests starting at age 40 for individuals with risk factors, such as a family history of prostate cancer.

Other side effects may include headache, joint or back pain, diarrhea, increased red blood cell count, anxiety, constipation, swelling of the legs, and increased prostate specific antigen (PSA ...